The pilosebaceous unit is part of the skin immune system

Dermatology

Volumn 196, Issue 1, 1998, Pages 75-79

  Bohm M ^a   Luger, Th A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

melanocyte stimulating hormone; Cytokines; Immune system; Neuropeptides; Pilosebaceous unit; Sebaceous gland

Indexed keywords

ANDROGEN RECEPTOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; NEUROPEPTIDE; NITRIC OXIDE; PEPTIDE; PROOPIOMELANOCORTIN; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; ELECTRON MICROSCOPY; HUMAN; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MACROPHAGE; MELANOCYTE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND; TARGET CELL;

ALPHA-MSH; ANIMALS; HAIR FOLLICLE; HUMANS; INTERLEUKIN-1; NEUROPEPTIDES; PRO-OPIOMELANOCORTIN; RATS; SEBACEOUS GLANDS; SEBUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642645408     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017874     Document Type: Conference Paper

References (38)

1. Luger T, Schwarz T: Epidermal Growth Factors and Cytokines. New York, Dekker, 1994.
2. Schauer E, Trautinger F, Köck A, Bhardwaj RS, Simon M, Schwarz A, Ansel JC, Schwarz T, Luger T: Proopiomelanocortin derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994;93:2258-2262.
3. Wintzen M, Gilchrest BA: Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 1996;106:3-10.
4. Luger T, Böhm M: Cytokines with immunosuppressive capacities; in Burg G, Dummer E (eds): Strategies for Immunointervention in Dermatology. Berlin, Springer, 1997, pp 101-117.
5. Böhm M, Schulte U, Hartmeyer M, Scholzen T, Becher E, Luger T: Human fibroblasts express melanocortin-1 receptors and respond to alpha-melanocyte stimulating hormone with increased secretion of interleukin-6 and interleukin-8. J Invest Dermatol 1997;108:593.
6. Hartmeyer M, Scholzen, T, Becher E, Bhardway RS, Fastrich M, Schwarz T, Luger TA: Human microvascular endothelial cells (HMEC-1) express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with α-MSH. J Immunol 1997;159:1930-1937.
7. Westgate GE, Craggs RI, Gibson WT: Immune privilege in hair growth. J Invest Dermatol 1991;97:417-420.
8. Paus R, Hoffmann U, Eichmüller S, Czarnetzki BM: Distribution and changing of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol 1994;130:281-289.
9. Hoffmann U, Tokura Y, Nishijima T, Takijawa M, Paus R: Hair cycle-dependent changes in skin immune functions: Anagen-associated depression of sensitization of the contact hypersensitivity in mice. J Invest Dermatol 1996;106:598-604.
10. Kolde G, Schulze-Osthoff K, Meyer H, Knop J: Immunohistological and immunoelectron microscopic identification of TNF-α in normal human and murine epidermis. Arch Dermatol Res 1992;284:154-158.
11. Ebling FJ, Ebling E, Skinner J: The influence of pituitary hormones on the response of the sebaceous glands of the rat to testosterone. J Endocrinol 1969;45:245-256.
12. Nikkari T, Valavaara M: The production of sebum in young rats: Effects of age, sex, hypophysectomy and treatment with somatotropic hormone and sex hormones. J Endocrinol 1969;43:113-118.
13. Thody AJ, Schuster S: The effects of hypophysectomy and testosterone on the activity of the sebaceous glands of castrated rats. J Endocrinol 1970;47:219-224.
14. Thody AJ, Schuster S: Control of sebum secretion by the posterior pituitary. Nature 1972;237:346-347.
15. Thody AJ, Schuster S: A possible role of MSH in the mammal. Nature 1973;245:207-209.
16. Thody AJ, Cooper MF, Meddis D, Bowden PE, Schuster S: The sebaceous gland response to ́-melanocyte-stimulating hormone and testosterone. J Endocrinol 1975;67:18P-19P.
17. Thody AJ, Meddis D, Schuster S: Increased sebaceous gland activity in the adult rat after α-melanocyte-stimulating hormone treatment during early life. J Invest Dermatol 1978;70:328-330.
18. Burton JL, Cunliffe WL, Millar DG, Schuster S: Effect of pregnancy on sebum excretion. Br J Med 1970;2:769-771.
19. Burton JL, Schuster S, Cartlidge M, Libman LJ, Martell U: Lactation, sebum excretion and melanocyte-stimulating hormone. Nature 1973;243:349-350.
20. Shizume K, Lerner AB: Determination of α-melanocyte-stimulating hormone in urine and blood. J Clin Endocrinol Metab 1954;14:1491-1510.
21. Pochi PE, Strauss JS, Mescon H: Sebum secretion and urinary 17-ketosteroid excretion in parkinsonism. J Invest Dermatol 1962;38:45-50.
22. Goolamali SK, Plummer N, Burton JL, Schuster S, Thody AJ: Sebum excretion and melanocyte-stimulating hormone in hypoadrenalism. J Invest Dermatol 1974;63:253-255.
23. Abdel-Malek Z, Swope VK, Susuki I, Akcali C, Harriger MD, Boyce ST, Urabc K, Hearing VJ: Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995;92:1789-1793.
24. Nanninga PB, Ghanem GE, Lejeune FJ, Bos JD, Westerhof W: Evidence for alpha-MSH binding sites on human scalp hair follicles: Preliminary results. Pigment Cell Res 1991;4:193-198.
25. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO: Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 1994;371:799-802.
26. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ: Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995;11:328-330.
27. Hornemann S, Seltmann H, Kodelja V, Orfanos CE, Zouboulis ChC: Interleukin-1α mRNA and protein are expressed in cultured human sebocytes at steady state and their levels are barely influenced by lipopolysaccharides. J Invest Dermatol 1997;108:382.
28. Kozlowska U, Blume-Peytavi U, Kodelja V, Sommer C, Goerdt S, Jablonska S, Orfanos CE: Proinflammatory interleukin-1 induces VEGF/VPF expression in cells of the human pilosebaceous unit. J Invest Dermatol 1997;108:382.
29. Slominski A, Paus R, Mazurkiewicz JE: Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 1992;48:50-54.
30. Slominski A, Wbrtsman J, Mazurkiewicz JE, Matsuoka L, Dietrich J, Lawrence K, Gorbani A, Paus R: Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993;122:658-666.
31. Lipton JM, Catania A: Antiinflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 1997;18:140-145.
32. Bhardwaj RS, Becher E, Mahnke K, Hartmeyer M, Schwarz T, Scholzen T, Luger TA: Evidence for the differential expression of the functional alpha melanocyte stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997;158:3378-3384.
33. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Riemann H, Aragane Y, Schwarz T, Luger T: Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996;156:2517-2521.
34. Luger TA, Köck A, Schauer E, Urbanski A, Trautinger F, Schwarz T: Cytokine neuropeptide interactions in the skin; in Van Vlotken WA, Lomabat WE (eds): Basic Mechanisms of Physiological and Aberrant Lymphoproliferation in the Skin. New York, Plenum Press, 1994, pp 95-102.
35. Broska T, Scholzen T, Hartmeyer M, Bletz S, Ebert K, Schwarz T, Luger TA: α-Melanocyte-stimulating hormone downregulates IL-1-induced chemokine expression in human keratinocytes via maintaining TL-RA expression. J Invest Dermatol (in press).
36. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA: α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996;156:473-478.
37. Zouboulis ChC, Xia LQ, Detmar M, Bogdanoff B, Giannakopoulis G, Gollnick H, Orfanos CE: Culture of human sebocytes and markers of sebocytic differentiation in vitro. Skin Pharmacol 1991;2:74-83.
38. Zouboulis ChC: Sebaceous cells in monolayer culture. In Vitro Cell Dev Biol 1992;28A:699.